source
- STAT roundup highlights obesity drug competition and other ADA conference updatesSTAT's ADA in 30 Seconds newsletter offers a brief snapshot of the American Diabetes Association's annual meeting, covering a range of topics for readers. Elaine Chen notes that the market for obe…
- Lilly presents safety data on obesity drug retatrutide, noting rare cardiac eventsEli Lilly reported new safety and tolerability findings for its next-generation obesity therapy retatrutide at the American Diabetes Association annual meeting. In the study, 7 of the 403 particip…